Form D · Biotechnology

NeXtGen Biologics, INC

Alachua, FL · CIK 0001620524

Offering snapshot reported Sep 22, 2025 · SEC filing

Reported sold
$130K
Offering amount: $5M
Investors reported
3
Form D · investor count
Minimum accepted
$30K
Reported outside-investor minimum
First sale
Jul 30, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 22, 2025Initial$130,000No comparison3SEC filing
Aug 17, 2020Initial$100,000No comparison1SEC filing
Dec 27, 2018Initial$2,160,500No comparison19SEC filing
May 24, 2017AmendmentYet to sellNo comparison0SEC filing
Jun 16, 2016InitialYet to sellNo comparison0SEC filing
Nov 23, 2015InitialYet to sellNo comparison0SEC filing
Sep 24, 2014Initial$500,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-558206

Source: Form D, filed Sep 22, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Gold Director
Jamie Grooms Director
Dan Hamister Director
Mark Hamister Director
Gerald Kluft Director
Elad Levy Director
Brian Lipke Director
Jonelle Toothman Director, Executive
Rick Wassel Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
13800 Tech City Circle Suite 200
Alachua, FL, 32615